Friday, July 4, 2014

Top 5 Dow Dividend Companies To Invest In 2015

Top 5 Dow Dividend Companies To Invest In 2015: Kamada Ltd (KMDA)

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company's product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other. Advisors' Opinion:
  • [By Monica Gerson]

    Kamada (NASDAQ: KMDA) shares fell 27.54% to $10.00 in pre-market trading after the company reported preliminary Alpha-1 Antitrypsin Phase II/III trial results.

  • [By Jake L'Ecuyer]

    Equities Trading UP
    Kamada (NASDAQ: KMDA) shares shot up 2.64 percent to $15.37 after the company announced the US proof-of-concept study with Glassia to treat GVHD.

  • [By Life Sciences Report]

    AF: Kamada Ltd. (KMDA) is a relatively unknown Israeli company that is doing very well. It is listed on the Tel Aviv Stock Exchange and the NASDAQ. It has an intravenous form of a drug for alpha-1 antitrypsin (AAT) deficiency, which causes lung and liver disease, that is partnered with Baxter International Inc. (BAX).

  • source from Top Stocks For 20! 15:http://www.topstocksblog.com/top-5-dow-dividend-companies-to-invest-in-2015.html

No comments:

Post a Comment